膈下逐瘀汤加减联合中医循经盆底肌康复对气虚血瘀型慢性盆腔痛的临床研究  

Clinical Study on Modified Gexia Zhuyu Decoction(膈下逐瘀汤加减)Combined with Pelvic Floor Muscle Rehabilitation along Meridians of Traditional Chinese Medicine in Treatment of Chronic Pelvic Pain with Qi Deficiency and Blood Stasis

作　　者：周璐 常淑华 陈嫣 ZHOU Lu;CHANG Shuhua;CHEN Yan(Ningbo Hospital of Traditional Chinese Medicine,Ningbo 315100,Zhejiang,China)

机构地区：[1]宁波市中医院,浙江宁波315100

出　　处：《中华中医药学刊》2024年第7期75-78,共4页Chinese Archives of Traditional Chinese Medicine

基　　金：国家中医药管理局全国名老中医药专家传承工作室建设项目(国中医药人教函[2022]75号)。

摘　　要：目的探讨膈下逐瘀汤加减联合中医循经盆底肌康复对气虚血瘀型慢性盆腔痛的临床效果。方法选择2019年12月—2022年12月医院收治的120例气虚血瘀型慢性盆腔痛患者作为研究对象,使用随机数字表通过简单随机的方法将其分为研究组与对照组,每组60例。对照组接受中医循经盆底肌康复训练,研究组在对照组的基础上,联合膈下逐瘀汤加减治疗,20 d为1个疗程,两组均治疗1个疗程,本研究随访3个月,比较两组治疗疗效,治疗前后下腹疼痛、腰骶疼痛、带下异常、劳累后加重、神疲乏力等主要症状积分,采用视觉模拟疼痛评分法(visual analogue scale, VAS)评估两组疼痛程度,比较治疗前、治疗后两组血清白细胞介素-6(interleukin 6,IL-6)水平差异,比较两组随访时复发情况。结果治疗后两组下腹疼痛、带下异常、腰骶疼痛、神疲乏力、劳累后加重积分均较本组治疗前明显降低,且研究组明显低于对照组(P<0.05),两组治疗后VAS评分均较本组治疗前明显降低,研究组低于对照组(P<0.05),两组治疗后血清IL-6水平均较本组治疗前明显降低,研究组低于对照组(P<0.05),研究组与对照组总有效率分别为95.00%(57/60)、83.33%(50/60)(P<0.05),研究组与对照组在随访时复发率分别为6.67%(4/60)、10.00%(6/60),差异无统计学意义(P>0.05)。结论膈下逐瘀汤加减联合中医循经盆底肌康复治疗气虚血瘀型慢性盆腔痛可明显缓解患者疼痛等症状,减轻炎症反应,具有较为显著的疗效,适合推广应用。Objective To investigate the clinical effect of Modified Gexia Zhuyu Decoction(膈下逐瘀汤加减)combined with pelvic floor muscle rehabilitation along meridians of traditional Chinese medicine on chronic pelvic pain with Qi deficiency and blood stasis.Methods A total of 120 patients with chronic pelvic pain with Qi deficiency and blood stasis treated in the hospital from December 2019 to December 2022 were selected as research objects.By using random number table,they were divided into study group and control group by simple random method,with 60 cases in each group.The control group received pelvic floor muscle rehabilitation training along meridians of traditional Chinese medicine.The study group combined with Modified Gexia Zhuyu Decoction.Twenty days was a course of treatment,and both groups were treated for 1 course of treatment.This study was followed up for 3 months,and the therapeutic efficacy of the two groups was compared.The scores of major symptoms including lower abdominal pain,lumbosacral pain,subband abnormalities and fatigue were compared before and after treatment,and the visual analog scale(VAS)was used to evaluate the pain of the two groups.The serum interleukin-6(IL-6)levels were compared between the two groups before and after treatment,and the recurrence rate was compared between the two groups during follow-up.Results After treatment,the scores of lower abdominal pain,underband abnormality,lumbosacral pain and fatigue aggravated in two groups were significantly lower than those before treatment,and the scores of the study group were significantly lower than those of the control group(P<0.05).VAS scores in two groups after treatment were significantly lower than those before treatment,and the scores of the study group were lower than those of the control group(P<0.05).The serum IL-6 level of the two groups after treatment was significantly lower than that of the control group(P<0.05).The total effective rate of the study group and the control group was 95.00%(57/60)and 83.33%(50/60),res

关 键 词：膈下逐瘀汤 中医循经 盆底肌康复 气虚血瘀型 慢性盆腔痛 

分 类 号：R271.911.33[医药卫生—中西医结合]